Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage

Asbtract Background There are limited neuroprotective treatment options for patients with aneurysmal subarachnoid hemorrhage (SAH). Cerebrolysin, a brain-specific proposed pleiotropic neuroprotective agent, has been suggested to improve global functional outcomes in ischemic stroke. We investigated...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Peter Y. M. Woo, Joanna W. K. Ho, Natalie M. W. Ko, Ronald P. T. Li, Leo Jian, Alberto C. H. Chu, Marco C. L. Kwan, Yung Chan, Alain K. S. Wong, Hoi-Tung Wong, Kwong-Yau Chan, John C. K. Kwok
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2020-11-01
Edice:BMC Neurology
Témata:
Aneurysmal subarachnoid hemorrhage
Neuroprotection
Delayed cerebral ischemia
On-line přístup:http://link.springer.com/article/10.1186/s12883-020-01908-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky